Orthosiphon stamineus (Misai Kucing) ameliorated postmenopausal osteoporosis in rat model

Menopause. 2018 Feb;25(2):202-210. doi: 10.1097/GME.0000000000000980.

Abstract

Objective: Orthosiphon stamineus (OS) or Misai Kucing (Java tea) is a popular herbal supplement from Southeast Asia for various metabolic, age-related diseases. This study investigated the potential use of OS leaf extracts to ameliorate osteoporosis in ovariectomized rats.

Methods: Fifty-six female Sprague-Dawley rats were randomly allocated into eight groups (n = 7): SHAM (healthy sham control); OVX (ovarietomized) nontreated rats (negative control); OVX + Remifemin (100 mg/kg body weight), and 2% green tea extract (positive controls); OVX + OS 50% ethanolic and aqueous extracts, both at either 150 or 300 mg/kg. After 16 weeks, the rats' bones and blood were evaluated for osteoporosis indicators (protein and mRNA expressions), micro-computed tomography for bone histomorphometry, and three-point bending test for tibia mechanical strength.

Results: The extracts dose-dependently and significantly (P < 0.05) improved bone strength and flexibility, bone mineral density, bone formation protein markers (P1NP), and bone histomorphometry. All extracts reduced the inflammation biomarker (interleukin-6). The extracts up-regulated osteoblastogenesis (bone morphogenetic protein-2) and collagen-1 synthesis (collagen type 1 alpha-1) mRNA expressions, and down-regulated bone resorption (TNFSF11 and nuclear factor-kappa B) mRNA expressions. Both the water and 50% ethanolic extract were effective. The effective dose is equivalent to 25 to 50 mg/kg extract for humans.

Conclusions: The extract showed bone-protective and antiosteoporotic effects (improving bone strength, flexibility, bone density, and bone morphometry) by reducing inflammation and the bone resorption biomarkers, while enhancing bone formation biomarkers and collagen synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Density / drug effects
  • Bone Morphogenetic Protein 2 / genetics
  • Bone Resorption / genetics
  • Bone and Bones / physiopathology
  • Collagen Type I / genetics
  • Collagen Type I, alpha 1 Chain
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Gene Expression / drug effects
  • Humans
  • Inflammation / blood
  • Interleukin-6 / blood
  • NF-kappa B / genetics
  • Orthosiphon*
  • Osteoporosis, Postmenopausal / diagnostic imaging
  • Osteoporosis, Postmenopausal / metabolism
  • Osteoporosis, Postmenopausal / pathology
  • Osteoporosis, Postmenopausal / prevention & control*
  • Osteoprotegerin / blood
  • Ovariectomy
  • Peptide Fragments / blood
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use*
  • Plant Leaves
  • Pliability / drug effects
  • Procollagen / blood
  • RANK Ligand / metabolism
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Teas, Herbal*
  • X-Ray Microtomography

Substances

  • Bmp2 protein, rat
  • Bone Morphogenetic Protein 2
  • Col1a1 protein, rat
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Il6 protein, rat
  • Interleukin-6
  • NF-kappa B
  • Osteoprotegerin
  • Peptide Fragments
  • Plant Extracts
  • Procollagen
  • RANK Ligand
  • Teas, Herbal
  • Tnfsf11 protein, rat
  • procollagen Type I N-terminal peptide